Corrigendum to "Saikosaponin-d Mediates FOXG1 to Reverse Docetaxel Resistance in Prostate Cancer through Oxidative Phosphorylation" [Mut. Res. - Fundam. Mol. Mech. Mutagenesis 829 (2024) 111875].
0/5 보강
APA
Meng J, Yang B, et al. (2025). Corrigendum to "Saikosaponin-d Mediates FOXG1 to Reverse Docetaxel Resistance in Prostate Cancer through Oxidative Phosphorylation" [Mut. Res. - Fundam. Mol. Mech. Mutagenesis 829 (2024) 111875].. Mutation research, 831, 111914. https://doi.org/10.1016/j.mrfmmm.2025.111914
MLA
Meng J, et al.. "Corrigendum to "Saikosaponin-d Mediates FOXG1 to Reverse Docetaxel Resistance in Prostate Cancer through Oxidative Phosphorylation" [Mut. Res. - Fundam. Mol. Mech. Mutagenesis 829 (2024) 111875].." Mutation research, vol. 831, 2025, pp. 111914.
PMID
40940204
같은 제1저자의 인용 많은 논문 (5)
- The role of MBD3 in cell biology and disease: Recent advances and future directions.
- A Prospective Phase 2 Trial of Hypofractionated Stereotactic Radiation Therapy for Patients With 1 to 10 Brain Metastases From Breast Cancer.
- Antitumor effects of Santalol on non-small cell lung cancer via disruption of NF-κB-mediated lipid metabolism.
- A lactylation-ferroptosis cross-talk gene signature predicts hepatocellular carcinoma prognosis and reveals STMN1/PRDX1 as therapeutic targets.
- In situ formed chemo-immunotherapeutic hydrogel for suppression of postoperative glioma recurrence and intraoperative hemostasis.